CSIMarket Company Name, Ticker, Customers, else..
 
Gilead Sciences Inc   (GILD)
Other Ticker:  
 
 

Gilead Sciences Inc Growth Comparisons

Select each growth Category to receive further Information



GILD Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -3.61 % -13.44 % -4.77 % 1.95 %
Q / Q Revenue Growth (Q1 MRQ) -14.03 % -9.74 % 1.46 % -5.1 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) -1.56 % -3.2 % -0.16 % %
Seq. Revenue Growth (for 12 months ending Q1 TTM) -0.87 % -3.13 % -0.97 % 0.34 %
Revenue 5 Year Average Growth 0.88 % 9.4 % 10.67 % 11.14 %


GILD's Growth Comparisons in I. Quarter 2023




Facing -3.61% year on year sales decrease in the first quarter 2023, to $ 6.35 billions, Gilead Sciences Inc reported smaller declines than the Biotechnology & Pharmaceuticals industry with -13.44%, and less than -4.77% decrease in the Healthcare sector. Slow first quarter sales in the Biotechnology & Pharmaceuticals industry and Healthcare sector, were portrayed in Gilead Sciences Inc 's results, which underperformed overall market.

Sequentially company's Revenue fell by -14.03% from the forth quarter results. . Looking into annual growth, sales grew by 0.88% on average in last five years, while S & P 500's including only Businesses with the first quarter 2023 earnings reports, average yearly sales growth is 11.14%.


Growth Rates of GILD's Income in the first quarter 2023


GILD Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) 765.48 % -50.53 % -5.64 % 2.76 %
Seq. Operating Income Change (Q1 MRQ) -24.79 % -61.5 % -27.04 % 1.53 %
Y / Y Operating Income Growth (Q1 TTM) 22.33 % -12.36 % -4.76 % 2.34 %
Seq. Operating Income Growth (Q1 TTM) 20.57 % 2.43 % 1.56 % 0.45 %
Operating Income 5 Year Avg. Change -12.29 % -11.19 % 10.54 % 11.25 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 8108.33 % - -24.37 % 2.19 %
Seq. Income from Cont. Ops. Change (Q1 MRQ) -39.68 % -57.27 % -24.01 % 16.18 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) 23.34 % -9 % -32.61 % -1 %
Seq. Income from Cont. Ops. Change (Q1 TTM) 21.31 % 61.67 % -0.85 % 0.62 %
Income from Cont. Ops. 5 Year Avg. Change -0.34 % 4.17 % 23.59 % 3.43 %

GILD Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 8108.33 % - -21.14 % 2.01 %
Q / Q Net Income Growth (Q1 MRQ) -39.68 % -49.99 % -21.57 % 13.9 %
Y / Y Net Income Change (Q1 TTM) 23.34 % -4.74 % -29.75 % -1.68 %
Seq. Net Income Change (Q1 TTM) 21.31 % 67.12 % -0.05 % 0.59 %
Net Income 5 Year Avg. Growth -0.34 % 3.27 % 23.59 % 3.71 %

GILD's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 3950 % - -24.37 % 2.19 %
Seq. EPS from Cont. Ops. Change (Q1 MRQ) -38.06 % -92.21 % -24.01 % 16.18 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) 24.04 % - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) 21.54 % - - -1.29 %
EPS from Cont. Ops. 5 Year Avg. Growth 0.67 % -9.22 % 23.59 % 3.43 %



GILD EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 3900 % - -21.14 % 3.43 %
Q / Q EPS Net Growth (Q1 MRQ) -38.34 % -90.88 % -21.57 % 13.9 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - -14.28 %
Seq. EPS Net Change (for 12 months ending Q1 TTM) 21.38 % - - -1.99 %
EPS Net 5 Year Avg. Change 0.73 % 3.27 % 23.59 % 3.71 %



Despite the -13.44% decline in Biotechnology & Pharmaceuticals industry, Gilead Sciences Inc showed impressive surge in EPS in the first quarter by 3900% from the same quarter a year ago, to $0.80, Healthcare sector declined -21.14%. Despite modest earnings per share in the Biotechnology & Pharmaceuticals industry and ind the Healthcare sector, Gilead Sciences Inc reported above average market earnings per share growth.

Bottom-line fell by -38.34% from the forth quarter results. Comparing the annual growth, income per share of 0.73% on average in last five years, to the S & P 500's, including only Businesses with the first quarter 2023 earnings, average yearly income per share growth is 3.71%. Gilead Sciences Inc grew less than the market.

GILD Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) -5.22 % -65.95 % -39.81 % 13.34 %
Seq. Free Cash Flow Change (Q1 MRQ) -32.06 % -78.03 % -65.04 % -65.53 %
Y / Y Free Cash Flow Change (Q1 TTM) -15.43 % -26.76 % 2.36 % 12.21 %
Seq. Free Cash Flow Change (Q1 TTM) -1.06 % -4.45 % 14.75 % 5.4 %
Free Cash Flow 5 Year Avg. Change -5.9 % 3.07 % 18.8 % 22.74 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - -
Seq. Net Cash Flow Change (Q1 MRQ) - - - -
Y / Y Net Cash Flow Change (Q1 TTM) 177.06 % - - -
Seq. Net Cash Flow Change (Q1 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - - -0.43 % 51.42 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -55.87 % 33.48 % 24.64 % 17.2 %
Seq. Capital Expenditures Change (Q1 MRQ) -39.78 % -4.31 % -24.48 % -29.03 %
Y / Y Capital Expenditures Change (Q1 TTM) -10.74 % 12.96 % 37.27 % -2.21 %
Seq. Capital Expenditures Change (Q1 TTM) -18.96 % 7.77 % 30.54 % 7.21 %
Capital Expenditures 5 Year Avg. Change 4.29 % 0.63 % 8.96 % 9.15 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071